| Sherry Anne Stevens, CPM, MHCM | |
|
124 Winona Rd, Meredith, NH 03253-6009 | |
| (603) 279-4197 | |
| Not Available |
| Full Name | Sherry Anne Stevens |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 124 Winona Rd, Meredith, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801932595 | NPI | - | NPPES |
| 30462183 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 1018 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sherry Anne Stevens, CPM, MHCM 124 Winona Rd, Meredith, NH 03253-6009 Ph: (603) 279-4197 | Sherry Anne Stevens, CPM, MHCM 124 Winona Rd, Meredith, NH 03253-6009 Ph: (603) 279-4197 |
News Archive
The Gateway for Cancer Research announces an exciting new Gateway-funded phase II study using ADAPT therapy for treatment of metastatic colorectal cancer based on a 2010 AACR presentation by Dr. Lin and his collaborators.
Illumina, Inc. today announced availability of its new TruSeq Custom Enrichment kits which enable researchers to economically design and target genomic regions of interest ranging from 700 kilobases (Kb) to 15 megabases (Mb) of cumulative DNA.
An analysis by Consumers Union has found that non-profit Blue Cross and Blue Shield health plans collected billions of dollars in surplus over the past decade while raising premiums for customers.
Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the second quarter ended June 30, 2010.
› Verified 3 days ago